Additional file 1 of Effect of the use of dapagliflozin in diuresis, natriuriesis, and in ultrafiltration and peritoneal elimination of sodium in patients with refractory heart failure: DAPA-DP study

Montomoli, Marco; Solano Rivera, Camila; Rico, Miguel Gonzalez; De la Espriella Juan, Rafael; Nuñez Marín, Gonzalo; Puchades Montesa, Maria Jesús; Gorriz Teruel, Jose Luis

doi:10.6084/m9.figshare.28068877.v1

Additional file 1 of Effect of the use of dapagliflozin in diuresis, natriuriesis, and in ultrafiltration and peritoneal elimination of sodium in patients with refractory heart failure: DAPA-DP study

journal contribution

posted on 2024-12-20, 04:53 authored by Marco Montomoli, Camila Solano Rivera, Miguel Gonzalez Rico, Rafael De la Espriella Juan, Gonzalo Nuñez Marín, Maria Jesús Puchades Montesa, Jose Luis Gorriz Teruel

Additional file 1.

Funding

AstraZeneca España

History

Usage metrics

Keywords

receiving standard therapies provide valuable insights known natriuretic efficacy innovative therapeutic approaches heart failure exacerbations demonstrated significant reductions refractory heart failure european medicines agency sodium retention remains sodium removal levels dietary sodium restrictions enroll 31 patients potential adverse effects increased sodium elimination optimizing hf management patients undergoing pd spanish agency refractory hf peritoneal elimination hf management sodium excretion sodium balance improving sodium pd patients patients unresponsive hf patients washout period trial registration statistical analysis safety profile reduced hospitalizations received approval previous meta potentially leading peritoneal effluent pd compared overall tolerability observed independently label approach investigated drug hospitalization days hf treated health products glucose cotransporter fluid balance effective technique clinical outcomes ceim file ceim ).cardiovascular complications assess changes 00 ).

Licence

CC BY + CC0

Additional file 1 of Effect of the use of dapagliflozin in diuresis, natriuriesis, and in ultrafiltration and peritoneal elimination of sodium in patients with refractory heart failure: DAPA-DP study

Funding

AstraZeneca España

History

Usage metrics

Categories

Keywords

Licence

Exports